Navigation Links
LMS to delist from Amex
Date:5/1/2008

MONTREAL, May 1 /PRNewswire-FirstCall/ - LMS Medical Systems (TSX: LMZ, AMEX: LMZ), a healthcare technology company and developer of the CALM- patient safety software system for obstetrics, today announced that its Board of Directors has unanimously decided to delist the Company's common shares from Amex.

The decision is in keeping with the Company's previous announcement to streamline operations and control costs in order to become cash flow positive. It is expected that Amex trading will cease on or about May 22, 2008.

LMS common shares will continue to be traded on the Company's principal exchange, the TSX.

About LMS: LMS is a leader in the application of advanced mathematical modeling and neural networks for medical use. The LMS CALM Suite provides physicians, nursing staff, risk managers and hospital administrators with clinical information systems and risk management tools designed to improve outcomes and patient care for mothers and their infants during childbirth.

Except for historical information contained herein, the matters discussed in this news release are forward-looking statements. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed implied by the forward-looking statements including, but without limitation, economic conditions in general and in the healthcare market, the demand for and market for our products in domestic and international markets, our current dependence on the CALM product suite, the challenges associated with developing new products and obtaining regulatory approvals if necessary, research and development activities, the uncertainty of acceptance of our products by the medical community, the lengthy sales cycle for our products, third party reimbursement, competition in our markets, including the potential introduction of competitive products by others, our dependence on our d
'/>"/>

SOURCE LMS MEDICAL SYSTEMS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Biotech delists shares from TSXV, continues OTCBB trading
2. XTL Announces Delisting From the Official List of the United Kingdom Listing Authority
3. American Stock Exchange LLC to Delist Securities of AMS Health Sciences, Inc.
4. HEI, Inc. Initiates Delisting and Deregistration of Its Shares on NASDAQ
5. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
6. Barrs PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange
7. QMed, Inc. Receives NASDAQ Delisting Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Ariz. July 24, 2014 A new study ... insights into the interplay among bacteria, viruses and the ... HIV-positive men,s infectivity their potential to infect others ... men produce large amounts of virus in their semen ... this "compartmentalization," where different levels of the virus can ...
(Date:7/24/2014)... London, UK (PRWEB) July 24, 2014 Memantine ... and was first marketed in Germany under the brand name ... and other nations as Ebixa and in the USA to ... of USD 420 million in 2013. In the US, Forest ... , Patent protection expiry in Canada, Australia and the European ...
(Date:7/24/2014)... IA (PRWEB) July 24, 2014 Members of ... Michael Wolnerman, RPh, CCIM, Senior Associate of Sales at OutcomesMTM, ... Governor appointed him to the Board and that his peers ... “I want to provide the best I can for the ... I am uniquely positioned to provide a special insight to ...
(Date:7/24/2014)... In a recent report by CBS News, the district capital ... criminal penalties associated with possession of small amounts of marijuana. ... Washington DC, giving it one of the most tolerant marijuana ... possession of one ounce of marijuana or less with a ... an ounce of marijuana remain criminal offenses under the new ...
(Date:7/24/2014)... women who received the Human Papillomavirus Vaccination (HPV) ... of abnormal Pap test results than those who ... journal Sexually Transmitted Diseases . , ... and School of Medicine conducted a cross-sectional study ... routine cervical cytology testing. HPV status and demographic ...
Breaking Medicine News(10 mins):Health News:TGen-led study seeks to understand why some HIV-positive men are more infectious 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 3Health News:Wolnerman Re-elected as Chairperson of Iowa State Board of Health 2Health News:Washington D.C. Decriminalizes Marijuana 2
... to Local Seniors, SAN FRANCISCO, June 10 ... to exercise their brains through the Brain Fitness ... partnership with San,Francisco-based Posit Science. The Brain Fitness ... memory and other cognitive functions,with participants reporting they ...
... addiction affordable, study says , , TUESDAY, June 10 ... have declined in recent years, but sales of non-cigarette ... cigarette sales by 30 percent, a Harvard School of ... data and found that between 2000 and 2007, cigarette ...
... expenses for chemotherapy may affect treatment decisions, expert ... Costs for treating Medicare patients with cancer increased ... The upward trend, seen with breast, lung and ... more patients are receiving radiation and chemotherapy, and ...
... popularity of golf carts has skyrocketed in recent years, ... injuries. In fact, a new study conducted by researchers ... The Research Institute at Nationwide Children,s Hospital found that ... during the 17-year study period. , According to ...
... June 10 Syneron(TM) Medical,Ltd. (Nasdaq: ... marketing and sales,of elos(TM) combined-energy medical aesthetic ... with Sono Bello Body Contouring,Centers for its ... thigh circumferential reduction device., Sono Bello ...
... CHAPEL HILL, N.C., June 10 Highly ... turnover and boost,corporate performance reside in less ... member-driven research study conducted by Best Practices,LLC,s ... satisfaction and engagement metrics and,ensure employees know ...
Cached Medicine News:Health News:30th Street Senior Center and Posit Science Put Their Heads Together On New Program 2Health News:30th Street Senior Center and Posit Science Put Their Heads Together On New Program 3Health News:Decline in Cigarette Sales Offset by Use of Alternative Products 2Health News:Medicare Costs for Cancer Treatment Soar 2Health News:Medicare Costs for Cancer Treatment Soar 3Health News:First national study to examine golf cart-related injuries 2Health News:Syneron Signs Multi-Year Exclusive Equipment Provider Agreement with Sono Bello Body Contouring Centers to Offer LipoLite(TM) and VelaShape(TM) 2Health News:Syneron Signs Multi-Year Exclusive Equipment Provider Agreement with Sono Bello Body Contouring Centers to Offer LipoLite(TM) and VelaShape(TM) 3Health News:Best-in-Class Engagement Programs: Employees See Link Between Quality & Performance 2
(Date:7/24/2014)... SOUTH PLAINFIELD, N.J. , July 24, 2014 /PRNewswire/ ... announced that the Company will host a webcast conference ... and provide an update on the company,s business and ... (ET) before the opening of the market. ... 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior ...
(Date:7/24/2014)... , Deutschland, und MARSEILLE ... -- , Weltweite ... ermöglicht QIAGEN die Entwicklung von Tests ... für Blutkrebs  Neuer Test weist ... mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf ...
(Date:7/24/2014)... -- Uroplasty, Inc. (NASDAQ: UPI ), a medical ... proprietary products to treat voiding dysfunctions, today reported ... ended June 30, 2014.  Global revenue for ... 19% to $4.1 million, as compared to $3.4 ... year.  Total revenue for the fiscal first quarter ...
Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11
... Ga., Nov. 8, 2011 GeckoSystems International Corporation (Pink ... announced today that they have successfully completed Alpha testing ... is a leader in the emerging mobile robotics industry, ... Security and Service™. "We are very ...
... International Isotopes Inc. (OTC Bulletin Board: INIS), a leading ... announce it has completed an agreement in principle ... for the production of Copper-67.  Copper-67 has shown ... as well as bladder, colorectal, and ovarian cancers. ...
Cached Medicine Technology:GeckoSystems Successfully Applies Its Mobile Robot Solutions to Improve Wheelchair Safety 2GeckoSystems Successfully Applies Its Mobile Robot Solutions to Improve Wheelchair Safety 3GeckoSystems Successfully Applies Its Mobile Robot Solutions to Improve Wheelchair Safety 4GeckoSystems Successfully Applies Its Mobile Robot Solutions to Improve Wheelchair Safety 5International Isotopes Inc. Announces the Completion of an Agreement in Principle With Idaho State University for the Production of Copper-67 for Experimental Use in Cancer Treatment 2International Isotopes Inc. Announces the Completion of an Agreement in Principle With Idaho State University for the Production of Copper-67 for Experimental Use in Cancer Treatment 3International Isotopes Inc. Announces the Completion of an Agreement in Principle With Idaho State University for the Production of Copper-67 for Experimental Use in Cancer Treatment 4
Volume: 2 ml; Volume Graduation: 1/100 ml...
... PipetBoy Pipettor is light as a feather and ... speed can be continuously adjusted. The pipette mount ... autoclaved. Two dosing knobs enable fine dosing to ... an/or glass pipettes from 0.1 to 100 ml. ...
Precise, safe, and fatigue-free series pipetting using graduated pip...
Inquire...
Medicine Products: